Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1139296

Influence of Ile655Val polymorphism on trastuzumab‐induced cardiotoxicity in early‐stage HER2 positive breast cancer


Vazdar, Ljubica; Gabrić, Ivo Darko; Kruljac, Ivan; Pintarić, Hrvoje; Šeparović, Robert; Kirigin Biloš, Lora Stanka; Pavlović, Mirjana; Tečić Vuger, Ana; Štefanović, Mario
Influence of Ile655Val polymorphism on trastuzumab‐induced cardiotoxicity in early‐stage HER2 positive breast cancer // Scientific reports, 11 (2021), 14395, 11 doi:10.1038/s41598-021-93634-6 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1139296 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Influence of Ile655Val polymorphism on trastuzumab‐induced cardiotoxicity in early‐stage HER2 positive breast cancer

Autori
Vazdar, Ljubica ; Gabrić, Ivo Darko ; Kruljac, Ivan ; Pintarić, Hrvoje ; Šeparović, Robert ; Kirigin Biloš, Lora Stanka ; Pavlović, Mirjana ; Tečić Vuger, Ana ; Štefanović, Mario

Izvornik
Scientific reports (2045-2322) 11 (2021); 14395, 11

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
breast cancer ; HER2 positive ; trastuzumab ; cardiac dysfunction

Sažetak
Trastuzumab has improved the prognosis of HER2 positive breast cancer, but cardiotoxicity remains a concern. We aimed to identify risk factors for trastuzumab-induced cardiotoxicity, with an emphasis on the HER2 Ile655Val single nucleotide polymorphism. This single- center case–control study included 1056 patients with early-stage HER2 positive breast cancer that received adjuvant trastuzumab. Cardiotoxicity was defined as a decline in left ventricular ejection fraction (LVEF) > 15% in patients without previous cardiomyopathy, or > 10% in patients with baseline LVEF of < 50%. Patient characteristics and cardiac parameters were compared in 78 (7.38%) cases and 99 randomly assigned controls, and the polymorphism was genotyped using real-time polymerase chain reaction. Cardiotoxicity was independently associated with advanced age (P = 0.024), lower body mass index (P = 0.023), left breast involvement (P = 0.001), N3 status (P = 0.004), diabetes (P = 0.016), and a family history of coronary artery disease (P = 0.019). Genotype distribution was as follows: A/A (Ile/Ile) was found in 111 (62.7%) patients, A/G (Ile/Val) in 60 (33.9%) patients, and G/G (Val/Val) in 6 (3.4%) patients. The genotype was not associated with cardiotoxicity or the severity of heart failure, reversibility, and recovery time. We found no association between the HER2 Ile655Val polymorphism and trastuzumab-induced cardiotoxicity ; therefore, we do not recommend routine cardiotoxicity-risk stratification using this polymorphism.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Stomatološki fakultet, Zagreb,
KBC "Sestre Milosrdnice"

Poveznice na cjeloviti tekst rada:

doi doi.org www.nature.com

Citiraj ovu publikaciju:

Vazdar, Ljubica; Gabrić, Ivo Darko; Kruljac, Ivan; Pintarić, Hrvoje; Šeparović, Robert; Kirigin Biloš, Lora Stanka; Pavlović, Mirjana; Tečić Vuger, Ana; Štefanović, Mario
Influence of Ile655Val polymorphism on trastuzumab‐induced cardiotoxicity in early‐stage HER2 positive breast cancer // Scientific reports, 11 (2021), 14395, 11 doi:10.1038/s41598-021-93634-6 (međunarodna recenzija, članak, znanstveni)
Vazdar, L., Gabrić, I., Kruljac, I., Pintarić, H., Šeparović, R., Kirigin Biloš, L., Pavlović, M., Tečić Vuger, A. & Štefanović, M. (2021) Influence of Ile655Val polymorphism on trastuzumab‐induced cardiotoxicity in early‐stage HER2 positive breast cancer. Scientific reports, 11, 14395, 11 doi:10.1038/s41598-021-93634-6.
@article{article, author = {Vazdar, Ljubica and Gabri\'{c}, Ivo Darko and Kruljac, Ivan and Pintari\'{c}, Hrvoje and \v{S}eparovi\'{c}, Robert and Kirigin Bilo\v{s}, Lora Stanka and Pavlovi\'{c}, Mirjana and Te\v{c}i\'{c} Vuger, Ana and \v{S}tefanovi\'{c}, Mario}, year = {2021}, pages = {11}, DOI = {10.1038/s41598-021-93634-6}, chapter = {14395}, keywords = {breast cancer, HER2 positive, trastuzumab, cardiac dysfunction}, journal = {Scientific reports}, doi = {10.1038/s41598-021-93634-6}, volume = {11}, issn = {2045-2322}, title = {Influence of Ile655Val polymorphism on trastuzumab‐induced cardiotoxicity in early‐stage HER2 positive breast cancer}, keyword = {breast cancer, HER2 positive, trastuzumab, cardiac dysfunction}, chapternumber = {14395} }
@article{article, author = {Vazdar, Ljubica and Gabri\'{c}, Ivo Darko and Kruljac, Ivan and Pintari\'{c}, Hrvoje and \v{S}eparovi\'{c}, Robert and Kirigin Bilo\v{s}, Lora Stanka and Pavlovi\'{c}, Mirjana and Te\v{c}i\'{c} Vuger, Ana and \v{S}tefanovi\'{c}, Mario}, year = {2021}, pages = {11}, DOI = {10.1038/s41598-021-93634-6}, chapter = {14395}, keywords = {breast cancer, HER2 positive, trastuzumab, cardiac dysfunction}, journal = {Scientific reports}, doi = {10.1038/s41598-021-93634-6}, volume = {11}, issn = {2045-2322}, title = {Influence of Ile655Val polymorphism on trastuzumab‐induced cardiotoxicity in early‐stage HER2 positive breast cancer}, keyword = {breast cancer, HER2 positive, trastuzumab, cardiac dysfunction}, chapternumber = {14395} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • Social Science Citation Index (SSCI)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font